Therapies for Children With Autism Spectrum Disorders

Evidence Table. Therapies for children with ASD (continued)
Study
Inclusion/ Exclusion
Description Intervention
Criteria/ Population
SFPE:
0.17 ± 0.56 (0-3)
Yoder and Stone,
2006a, 2006b
Yoder and
Lieberman, 2009†
(continued)
Yoder and Stone,
2006a, 2006b
Yoder and
Lieberman, 2009†
(continued)
Baseline
Measures Outcomes
mean ± SD:
G1: 5.5 ± 3.2
G2: 5.4 ± 3.2
P = 0.96
Number of nonimitative
Number of
spoken communication
different non-
acts in SFPE:
imitative words, 6
0.25 ± 0.84 (0-4)
months, adjusted*
Number of communication
group mean ± SD:
acts in SFPE:
G1: 3.1 ± 2.4
8.4 ± 10.5 (0-56)
G2: 2.9 ± 2.4
Proportion of
P = 0.93
communication acts that
Harms:
are intentional
NR
communication in SFPE:
Modifiers:
0.89 ± 0.21 (0-1.0)
Baseline ADOS
Proportion of
negatively
communication acts that
correlated with
are spoken words in SFPE:
post-treatment
0.05 ± 0.18 (0-1.0)
frequency of
requests in the
ESCS (r = -0.35,
P = 0.04) and
initiating joint
attention in the
unstructured free
play session (r =
-0.40, P = 0.007)
Baseline object
exchange turns
correlated with
post-treatment
frequency of
object exchange
turns (r = 0.65,
P < 0.001)
Baseline initiating
joint attention
predicted
differential
treatment effects
on post-treatment
initiating joint
attention
(P < 0.001) and
differential
response to
treatments on
post-treatment
requests in the
ESCS (P = 0.003)
Interaction
between initial
interest in a
variety of objects
and treatment (P
= 0.01) predicting
C-112